Navigation Links
Durasphere® EXP Injectable Bulking Agent

ProductsDurasphere® EXP Injectable Bulking Agent
Company Boston Scientific Corporation
Item Durasphere® EXP Injectable Bulking Agent
Features 
  • Exceptional Agent Delivery: Durasphere EXP Injectable Bulking Agent is designed to flow more easily down the delivery needle to reduce delivery obstruction
  • Long Term Durability: 73% of patients who participate in the IDE study reported that they maintained their 1-year post procedure continence grade at 4.3 years post procedure
  • Biocompatible: Pyrolytic carbon coating has been used for 30 years in the heart valve industry
  • Convenient: No skin test necessary. No refrigeration required.
  • Needle Options: Multiple needles available to support both a transurethral or submucosal technique
Description New Durasphere EXP Injectable Bulking Agent is composed of pyrolytic carbon-coated beads suspended in a water-based carrier gel. Durasphere EXP Injectable Bulking Agent is indicated for the treatment of adult women with stress urinary incontinence due to intrinsic sphincter deficiency.
Info Boston Scientific Corporation
Customer Service: (888) 272-1001
Web site: http://www.bostonscientific.com

Related medicine products :

1. Perfect Pupil Injectable
2. C-flex™ - Acrylic UV Injectable Lens System Pack
3. Disposable Injectable Monopolar Needle Electrodes
4. Handbook on Injectable Drugs, 13th Ed.
5. Sculptra® Injectable Poly-L-Lactic Acid
6. Zyderm® and Zyplast® Injectable Collagen Implants
7. Myobloc®(Botulinum Toxin Type B) Injectable Solution
8. Streck-Lysing Agent III Lytic Reagent
9. Streck-Lysing Agent IIIC Lytic Reagent
10. Streck-Lysing Agent IIIA Lytic Reagent
11. Streck-MD-Pack Diluent and Lysing Agent
... is the primary active hormone synthesized within ... [1]. T4 is synthesized via a series ... the follicular cells, (ii) iodination of tyrosine ... formation of 3-monoiodotyrosine and 3,5-diiodotyrosine (MIT and ...
... growth factor binding protein-3 (IGFBP-3) is the main ... serum, as a component of the ~150 kDa ... molecule of IGF-I or IGF-II and ALS, allowing ... of the IGFs. The molar concentration of IGFBP-3 ...
... Growth hormone (GH) is a monomeric protein ... anterior pituitary gland. GH is released from ... pulsatile manner under the regulatory control of ... [1]. The timing and frequency of GH ...
... I (IGF-I or somatomedin C) is a 7.6 ... acts as a potent mitogen of cellular proliferation, ... receptors. In the circulation, IGF-I is bound to ... actions of IGF-I by modulating the interaction of ...
Medicine Products:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... ... ... Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and Mental ... exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took place ... BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive an ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
Breaking Medicine Technology: